IFNAR1 antibody (AA 353-364)

Catalog No. ABIN1590142

This Goat Polyclonal antibody specifically detects IFNAR1 in WB and ELISA. It exhibits reactivity toward Human.

Quick Overview for IFNAR1 antibody (AA 353-364) (ABIN1590142)

Target: IFNAR1 (Interferon alpha/beta Receptor 1 (IFNAR1))

Reactivity: Human

Host: Goat

Clonality: Polyclonal

Conjugate: This IFNAR1 antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Grade: Verified

Product Details anti-IFNAR1 Antibody

Binding Specificity: AA 353-364

Purpose: IFNAR1 (aa353-364)

Sequence: PKQSGNTPVI QD

Cross-Reactivity: Human

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Isotype: IgG

Application Details

Application Notes:

Western Blot: Approx 65 kDa band observed in lysates of cell line K562 (calculated MW of 63.5 kDa according to NP_000620.2). Recommended concentration: 0.3-1 μg/mL.

Peptide ELISA: antibody detection limit dilution 1:128000.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handling Advice: Minimize freezing and thawing.

Storage: -20 °C

Storage Comment: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Target Details for IFNAR1

Target: IFNAR1 (Interferon alpha/beta Receptor 1 (IFNAR1))

Alternative Name: IFNAR1

Background: IFNAR1, interferon (alpha, beta and omega) receptor 1, AVP, IFN-alpha-REC, IFNAR, IFNBR, IFRC, CRF2-1, IFN-R-1, IFN-alpha/beta receptor 1, alpha-type antiviral protein, beta-type antiviral protein, cytokine receptor class-II member 1, cytokine receptor fa

Gene ID: 3454

NCBI Accession: NP_000620

Pathways: JAK-STAT Signaling, Hepatitis C